Syllabus for Molecular Biopharmaceutics
A revised version of the syllabus is available.
- 7.5 credits
- Course code: 3FG288
- Education cycle: Second cycle
Main field(s) of study and in-depth level:
Pharmaceutical Sciences A1N,
Drug Discovery and Development A1N
Explanation of codes
The code indicates the education cycle and in-depth level of the course in relation to other courses within the same main field of study according to the requirements for general degrees:
- G1N: has only upper-secondary level entry requirements
- G1F: has less than 60 credits in first-cycle course/s as entry requirements
- G1E: contains specially designed degree project for Higher Education Diploma
- G2F: has at least 60 credits in first-cycle course/s as entry requirements
- G2E: has at least 60 credits in first-cycle course/s as entry requirements, contains degree project for Bachelor of Arts/Bachelor of Science
- GXX: in-depth level of the course cannot be classified
- A1N: has only first-cycle course/s as entry requirements
- A1F: has second-cycle course/s as entry requirements
- A1E: contains degree project for Master of Arts/Master of Science (60 credits)
- A2E: contains degree project for Master of Arts/Master of Science (120 credits)
- AXX: in-depth level of the course cannot be classified
- Grading system: Fail (U), Pass (G), Pass with distinction (VG)
- Established: 2016-05-26
- Established by:
- Revised: 2022-02-28
- Revised by: Programme coordinator Per Larsson
- Applies from: Autumn 2022
- Master of Science Programme in Pharmacy: the student should have 150 credits within the programme and passed the courses in pharmaceutics and pharmacokinetics (7.5 credits). All course included during semester 1-7 should have been studied.
- Bachelor of Science Programme in Pharmacy: the student should have at least 120 credits within the programme and passed the courses in pharmaceutics and physical chemistry and pharmacokinetics. All mandatory courses during semester 1-5 should have been studied.
- Master Programme in Chemical Engineering: the student should have at least 120 credits including the program courses in pharmaceutics and pharmacokinetics.
- Accepted to Master Programme in Pharmaceutical Modelling.
- Freestanding course: 150 credits including 60 credits pharmaceutical sciences with basic education in pharmaceutics and pharmacokinetics. Other education will be evaluated individually.
Knowledge in English equivalent to that required for basic eligibility to Swedish higher education.
- Responsible department: Department of Pharmacy
After having completed the course, the student should
- understand the role of biopharmaceutics in the drug discovery and development process.
- be able to explain biopharmaceutical, physiological, biochemical and cellbiological aspects on drug transport and metabolism in the gastrointestinal tract and liver.
- be able to analyse the drug transport and metabolism mechanisms of importance for drug-drug interactions under given circumstances (effect of fed state, medications and impact on certain population groups).
- be knowledgeable about and able to apply computational and experimental methods to study drug transport and metabolism and interactions.
- be able to explain regulatory demands of importance for biopharmaceutical evaluation.
- be able to plan, compile, analyse and present experiments, as well as critically read, analyse and present scientific papers of relevance to biopharmaeceutics.
- explain regulatory demands of importance for biopharmaceutical evaluation.
- developed tha ability to reflect upon and orally present scientific literature
Physiological, biochemical and cellbiological background to the gastrointestinal tract and liver, and how these can be related to drug transport and metabolism.
Basic understanding of methods used to study dissolution, permeability, transit time, stability, metabolism and physiology-based pharmacokinetics (PBPK). These include in silico, in vitro, in situ and in vivo methods used to elucidate possibilities and limitations in predictions of biopharmaceutical processes in humans.
Mechanistical insights to cellular transport processes and metabolism are provided to understand molecular features of importance for drug transport and clearance. Drug-drug interactions and interactions with food and the relevance of such interactions for intestinal drug absorption, liver distribution and extraction.
Overview of principles to formulate different types of problematic drug molecules and when other administration routes than the oral are suitable.
Regulatory aspects on drug absorption, bioavailability and bioequivalence based on guidelines from the regulatory authorities (e.g. FDA, EMA).
The teaching is based on lectures, seminars, exercises, computational and experimental laboratory work and a literature study.
Compulsory sections: exercises, laboratory work, literature study.
Examination is performed at the end of the course. In addition, passing the course requires presence during compulsory sections of the course and approved examination of laboratory work and literature study. Possibility to redo or complement compulsory sections can earliest be provided the next semester in case of vacancies.
If there are special reasons for doing so, an examiner may make an exception from the method of assessment indicated and allow a student to be assessed by another method. An example of special reasons might be a certificate regarding special pedagogical support from the University's disability coordinator.
- Latest syllabus (applies from Autumn 2023)
- Previous syllabus (applies from Autumn 2022)
- Previous syllabus (applies from Spring 2021)
- Previous syllabus (applies from Autumn 2019, version 2)
- Previous syllabus (applies from Autumn 2019, version 1)
- Previous syllabus (applies from Autumn 2018)
- Previous syllabus (applies from Autumn 2017)
Applies from: Autumn 2022
Some titles may be available electronically through the University library.